New Delhi, Feb 04: On the occasion of World Cancer Day, Dr. Sudhir Srivastava underscored the growing role of indigenous surgical robotics in transforming cancer care in India by improving precision, outcomes, and most importantly access to advanced treatment beyond metropolitan centres.
Cancer continues to be one of the most complex healthcare challenges globally, requiring not only medical excellence but also timely and equitable access to care. As surgical oncology evolves, robotic-assisted surgery is increasingly being adopted for its ability to enhance surgical accuracy, minimise trauma, and support faster recovery- key factors in improving patient outcomes and quality of life.
Speaking on the importance of accessibility in cancer treatment, Dr. Sudhir Srivastava, Founder, Chairman & CEO, SS Innovations International Inc., said: “Cancer remains one of the most challenging health conditions of our time, affecting not just patients but entire families. The journey through treatment is as much about timely access and trust as it is about medical precision. Robotic-assisted surgery is playing an important role in improving cancer care by enabling greater accuracy, reducing surgical trauma, and supporting faster recovery for patients. On World Cancer Day, it is crucial to address the question of access. In countries like India, advanced surgical care has historically been limited to a handful of metropolitan centres, making timely treatment difficult for patients in smaller cities. At SS Innovations, we are actively changing this scenario. By developing affordable, Made-in-India surgical robotic systems, we have been able to expand access to advanced care, with a majority of our installations today located in Tier II and Tier III cities. This is helping ensure that high-quality, precision-led cancer care reaches patients closer to where they live, making advanced surgical treatment more accessible and equitable across the country.”
Dr. Srivastava further emphasised that World Cancer Day serves as a reminder that innovation must go hand in hand with inclusivity. Indigenous medical technology, particularly in surgical robotics, has the potential to bridge the long-standing gap between clinical excellence and affordability, ensuring that advanced cancer care is no longer confined to large urban hospitals.
Through its focus on Made-in-India innovation, SS Innovations continues to work towards democratising robotic surgery, enabling hospitals across Tier II and Tier III cities to offer advanced, precision-led cancer surgeries closer to patients’ homes—reducing travel burden and improving timely intervention. SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSII Mantra” surgical robotic system and its comprehensive suite of “SSII Mudra” surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations International plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.